Nomura Flags Post-Period Data Breach in H1 Semi-Annual Report
NMR sits 34% above its 52-week low of $6.88 on elevated volume (3.9× avg).
Summary
Nomura's semi-annual report re-confirms H1 net income of ¥249.3 billion (up 26.8%) while disclosing, for the first time, a post-September 30 data breach and ¥61 billion of reasonably possible legal losses.
Key Events · Legal and Risk Events · NMR
-
Post-Period Data Breach Disclosed
After September 30, 2026, Nomura confirmed unauthorized access to and information leakage in connection with services it provides, and it also flagged leakage at outsourced service providers. The filing cautions that the affected information or the scope of impact may prove more extensive than initially identified.
-
H1 Net Income ¥249.3 Billion
Six-month net income attributable to shareholders climbed to ¥249.3 billion from ¥196.6 billion, on net revenue of ¥1,294.2 billion versus ¥1,038.8 billion. Diluted EPS came in at ¥82.97 against ¥64.53.
-
¥61 Billion Possible Legal Loss
As of November 16, 2026, Nomura puts the aggregate reasonably possible maximum loss in excess of recognized liabilities at approximately ¥61 billion across cases where a range can be estimated; ¥11.5 billion was recognized as a liability at September 30, 2026.
-
CFTC Matter Settled and Closed
A settlement finalized on August 28, 2026 resolved all claims in the CFTC's swap-trading enforcement action, and the CFTC terminated its investigation on September 2, 2026.
Analysis · NMR · Finance
The headline numbers were already out: net income of ¥249.3 billion for the six months ended September 30, 2026, up from ¥196.6 billion a year earlier, with diluted EPS of ¥82.97 versus ¥64.53. What is new sits in the risk factors. Nomura confirmed unauthorized access to and information leakage from its own services after the period end, along with leakage at outsourced providers, and warns the affected scope could widen as investigations proceed. That is an unquantified operational and reputational risk layered on a business already carrying ¥61 billion of reasonably possible legal losses beyond what it has booked. Separately, the filing confirms Ernst & Young ShinNihon signed an unqualified interim review on November 16, 2026, and that the CFTC swap-trading matter was settled on August 28, 2026, with the investigation terminated September 2, 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NMR was trading at $9.21 on NYSE in the Finance sector, with a market capitalization of approximately $26.6B. The 52-week trading range was $6.88 to $10.94. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.